ArticleGlobal cardiology science & practice2025
Cardiac function and atrial conduction time in morbid obesity: Insights from an echocardiographic case-control study.
Article in Global cardiology science & practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity, especially morbid obesity, is linked to increased cardiovascular risk, including potential abnormalities in atrial conduction and changes in cardiac structure. This study examines the impact of morbid obesity on atrial conduction time (ACT) and associated echocardiographic parameters.
methodsThis case-control study involved 100 patients from Imam Hossein Hospital, Tehran, including 50 with morbid obesity and 50 with normal BMI. Demographic, clinical, and echocardiographic data were collected. ACT was measured, and echocardiographic parameters including left atrial septum thickness, posterior wall thickness, and mitral valve peak early diastolic velocity (MV.PAV.1) were evaluated.
resultsThe morbid obesity group exhibited significantly prolonged ACT (
conclusionsMorbid obesity is associated with prolonged ACT and increased echocardiographic measurements of left atrial septum thickness, posterior wall thickness, and MV.PAV.1. These findings suggest that morbid obesity adversely affects atrial conduction and cardiac structure, highlighting the need for targeted cardiovascular risk management in obese patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.